Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Methadone exposures reported to poison control centers in the United States following the COVID-19-related loosening of federal methadone regulations
Christopher Welsh, Suzanne Doyon, Katherine Hart
International Journal of Drug Policy (2022) Vol. 102, pp. 103591-103591
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatment for opioid use disorder: implications for policy
Noa Krawczyk, Bianca Rivera, Emily Levin, et al.
The Lancet Public Health (2023) Vol. 8, Iss. 3, pp. e238-e246
Open Access | Times Cited: 57
Methadone-involved overdose deaths in the United States before and during the COVID-19 pandemic
Robert A. Kleinman, Marcos Sanches
Drug and Alcohol Dependence (2022) Vol. 242, pp. 109703-109703
Open Access | Times Cited: 21
Access to tablet injectable opioid agonist therapy in rural and smaller urban settings in British Columbia, Canada: a qualitative study
Geoff Bardwell, Jeanette M. Bowles, Manal Mansoor, et al.
Substance Abuse Treatment Prevention and Policy (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 13
Examination of methadone involved overdoses during the COVID-19 pandemic
Daniel E. Kaufman, Amy L. Kennalley, Kenneth L. McCall, et al.
Forensic Science International (2023) Vol. 344, pp. 111579-111579
Open Access | Times Cited: 12
Racial, Ethnic, and Sex Differences in Methadone-Involved Overdose Deaths Before and After the US Federal Policy Change Expanding Take-home Methadone Doses
Rebecca Arden Harris, Judith A. Long, Yuhua Bao, et al.
JAMA Health Forum (2023) Vol. 4, Iss. 6, pp. e231235-e231235
Open Access | Times Cited: 10
Methadone-Involved Overdose Deaths in Urban and Rural Communities Before and After the Public Health Emergency Flexibilities for Methadone Take-Home Doses
Rebecca Arden Harris, Judith A. Long, Yuhua Bao, et al.
Drug and Alcohol Dependence Reports (2025), pp. 100339-100339
Open Access
Methadone for Opioid Use Disorder in the Fentanyl Era: Navigating Challenges and Evolving Strategies- a Narrative Review
Eugene Osagie, James L. Horton, David Lawrence, et al.
Current Addiction Reports (2025) Vol. 12, Iss. 1
Closed Access
Patient experiences of methadone treatment changes during the first wave of COVID-19: a national community-driven survey
Sarah Brothers, Adam Palayew, Caty Simon, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 7
Examining inequities in access to opioid agonist treatment (OAT) take-home doses (THD): A Canadian OAT guideline synthesis and systematic review
Cayley Russell, Jenna Ashley, Farihah Ali, et al.
International Journal of Drug Policy (2024) Vol. 127, pp. 104343-104343
Open Access | Times Cited: 2
“Sign Me Up”: a qualitative study of video observed therapy (VOT) for patients receiving expedited methadone take-homes during the COVID-19 pandemic
James Darnton, Elenore P. Bhatraju, Kristin Beima‐Sofie, et al.
Addiction Science & Clinical Practice (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Increase in hospitalisation-associated methadone intoxication in France following first COVID-19 lockdown
Justine Perino, M. Demourgues, H. Ramaroson, et al.
Public Health (2023) Vol. 223, pp. 1-6
Open Access | Times Cited: 4
Dynamic changes in methadone utilisation for opioid use disorder treatment: a retrospective observational study during the COVID-19 pandemic
Amy L. Kennalley, Jessica L. Fanelli, John A. Furst, et al.
BMJ Open (2023) Vol. 13, Iss. 11, pp. e074845-e074845
Open Access | Times Cited: 4
Effectiveness of take-home methadone treatment among patients with opioid use disorders during COVID-19: A systematic review
Shabnam Naher, Sabbir Pervez, Feroz Ahmed, et al.
Health Sciences Review (2024) Vol. 12, pp. 100195-100195
Open Access | Times Cited: 1
Reversal of increases in methadone distribution for opioid use disorder in the US during the COVID-19 pandemic
Amy L. Kennalley, Jessica L. Fanelli, John A. Furst, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Individualizing methadone treatment with split dosing: An underutilized tool
Hannan M. Braun, Ruth A. Potee
Journal of Substance Use and Addiction Treatment (2023) Vol. 152, pp. 209096-209096
Closed Access | Times Cited: 3
Impact of COVID-19-related methadone regulatory flexibilities: views of state opioid treatment authorities and program staff
Shannon Gwin Mitchell, Julia Jester, Jan Gryczynski, et al.
Addiction Science & Clinical Practice (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 3
Augmentation des surdoses et décès en lien avec la consommation de méthadone durant la crise sanitaire liée au COVID-19 en 2020
Élisabeth Frauger, Nathalie Fouilhé, Clémence Lacroix, et al.
Therapies (2023) Vol. 79, Iss. 3, pp. 297-306
Open Access | Times Cited: 2
Clinics Optimizing MEthadone Take-homes for opioid use disorder (COMET): Protocol for a stepped-wedge randomized trial to facilitate clinic level changes
Sugy Choi, Megan A. O’Grady, Charles M. Cleland, et al.
PLoS ONE (2023) Vol. 18, Iss. 6, pp. e0286859-e0286859
Open Access | Times Cited: 1
Accidental Overdosing in Patients with Take-Home Methadone – A Case Series
Anshul Sharma, Sidharth Arya, Gunjan Chadha, et al.
Annals of Indian Psychiatry (2024)
Open Access
Should Providers Advocate for Their Patients?
Edmund G. Howe
The Journal of Clinical Ethics (2024) Vol. 35, Iss. 2, pp. 77-84
Closed Access
Methadone treatment utilization and overdose trends among Medicaid beneficiaries in New Jersey before and during the COVID-19 pandemic
James F. Lloyd, Peter Treitler, Jamey J. Lister, et al.
Journal of Substance Use and Addiction Treatment (2024) Vol. 167, pp. 209476-209476
Open Access
Methadone overdoses increased 48% during the COVID-19 epidemic
Daniel E. Kaufman, Amy L. Kennalley, Kenneth L. McCall, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Established Tables and Emergent Huddles: Exploring the Processes of Participation Associated With the Policy Changes to Opioid Pharmacotherapy Treatment in Australia in the Context of COVID-19
Richard Mellor, Matthew Kearnes, Kari Lancaster, et al.
Contemporary Drug Problems (2022) Vol. 49, Iss. 4, pp. 385-404
Open Access | Times Cited: 1
Synthesizing evidence on the impacts of COVID-19 regulatory changes on methadone treatment for opioid use disorder: Implications for U.S. federal policy
Noa Krawczyk, Bianca Rivera, Emily Levin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Evaluating the Impact of Increased Dispensing of Opioid Agonist Therapy Take-Home Doses on Treatment Retention and Opioid-Related Harm among Opioid Agonist Therapy Recipients: A Simulation Study
Narjes Shojaati, Nathaniel Osgood
Systems (2023) Vol. 11, Iss. 8, pp. 391-391
Open Access
Page 1 - Next Page

Scroll to top